BRPI0511095B8 - um processo para produção de enantiômero de anlodipino em alta pureza ótica - Google Patents
um processo para produção de enantiômero de anlodipino em alta pureza óticaInfo
- Publication number
- BRPI0511095B8 BRPI0511095B8 BRPI0511095A BRPI0511095A BRPI0511095B8 BR PI0511095 B8 BRPI0511095 B8 BR PI0511095B8 BR PI0511095 A BRPI0511095 A BR PI0511095A BR PI0511095 A BRPI0511095 A BR PI0511095A BR PI0511095 B8 BRPI0511095 B8 BR PI0511095B8
- Authority
- BR
- Brazil
- Prior art keywords
- optical purity
- high optical
- enantiomer
- producing amlodipine
- amlopidine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN1123/MUM/2004 | 2004-10-20 | ||
IN1123MU2004 | 2004-10-20 | ||
PCT/IB2005/003108 WO2006043148A1 (en) | 2004-10-20 | 2005-10-17 | Process for producing enantiomer of amlodipine in high optical purity |
Publications (3)
Publication Number | Publication Date |
---|---|
BRPI0511095A BRPI0511095A (pt) | 2007-12-26 |
BRPI0511095B1 BRPI0511095B1 (pt) | 2021-01-19 |
BRPI0511095B8 true BRPI0511095B8 (pt) | 2021-05-25 |
Family
ID=35708803
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0511095A BRPI0511095B8 (pt) | 2004-10-20 | 2005-10-17 | um processo para produção de enantiômero de anlodipino em alta pureza ótica |
Country Status (11)
Country | Link |
---|---|
US (2) | US7858801B2 (pt) |
EP (1) | EP1802576B1 (pt) |
JP (1) | JP4932728B2 (pt) |
KR (1) | KR101130622B1 (pt) |
AT (1) | ATE399154T1 (pt) |
BR (1) | BRPI0511095B8 (pt) |
DE (1) | DE602005007763D1 (pt) |
ES (1) | ES2307209T3 (pt) |
PT (1) | PT1802576E (pt) |
RU (1) | RU2376288C2 (pt) |
WO (1) | WO2006043148A1 (pt) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HUP0500570A3 (en) * | 2005-06-08 | 2008-03-28 | Richter Gedeon Nyrt | Process for the preparation of (s)-(-)-amlodipine |
KR100913791B1 (ko) * | 2006-07-21 | 2009-08-26 | 한미약품 주식회사 | (s)-(-)-암로디핀 캠실레이트 또는 이의 수화물 및 이를함유하는 약학적 조성물 |
WO2008026838A1 (en) * | 2006-08-30 | 2008-03-06 | Chemtech Research Incorporation | Method for preparing an optically active amlodipine |
KR100828883B1 (ko) * | 2006-10-27 | 2008-05-09 | 씨제이제일제당 (주) | 라세믹 암로디핀으로부터 s-(-)-암로디핀의 분리방법 |
CN101766611B (zh) * | 2010-02-09 | 2011-10-12 | 施慧达药业集团(吉林)有限公司 | 一种左旋氨氯地平或其可药用盐和β受体阻滞剂的药物组合物及其应用 |
CN101773500B (zh) * | 2010-02-09 | 2012-05-23 | 施慧达药业集团(吉林)有限公司 | 抗高血压的药物组合物 |
KR101313842B1 (ko) * | 2010-09-15 | 2013-10-01 | 대화제약 주식회사 | 에스-암로디핀 베실레이트 및 그 수화물의 제조방법 |
CN111689894B (zh) * | 2019-03-13 | 2023-05-02 | 鲁南制药集团股份有限公司 | 一种苯磺酸左旋氨氯地平晶型 |
CN112110850B (zh) * | 2019-06-20 | 2023-05-02 | 鲁南制药集团股份有限公司 | 一种苯磺酸左旋氨氯地平新晶型 |
CN110882249B (zh) | 2019-11-08 | 2021-04-30 | 北京吾为尔创科技有限公司 | 含苯磺酸左氨氯地平水合物的组合物及其制备方法 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8804630D0 (en) | 1988-02-27 | 1988-03-30 | Pfizer Ltd | Preparation of r-& s-amlodipine |
CA2124445A1 (en) * | 1991-11-26 | 1993-06-10 | James W. Young | Methods and compositions for treating hypertension, angina and other disorders using optically pure (-) amlodipine |
US6057344A (en) | 1991-11-26 | 2000-05-02 | Sepracor, Inc. | Methods for treating hypertension, and angina using optically pure (-) amlodipine |
GB9317773D0 (en) | 1993-08-26 | 1993-10-13 | Pfizer Ltd | Therapeutic compound |
GB9405833D0 (en) * | 1994-03-24 | 1994-05-11 | Pfizer Ltd | Separation of the enantiomers of amlodipine |
CN1100038C (zh) | 2000-02-21 | 2003-01-29 | 张喜田 | 氨氯地平对映体的拆分 |
JP2005509637A (ja) | 2001-10-24 | 2005-04-14 | セプラコア インク. | アムロジピンラセミ体の分離方法 |
US20030176706A1 (en) | 2002-03-18 | 2003-09-18 | Joshi Rohini Ramesh | Process for the preparation of [S(-) amlodipine - L (+)- hemitartarate] |
EP1348697A1 (en) | 2002-03-28 | 2003-10-01 | Council Of Scientific & Industrial Research | Process for the preparation of S(-)-amlodipine-L(+)-hemitartrate |
KR100476636B1 (ko) | 2002-09-11 | 2005-03-17 | 한림제약(주) | 엘-(+)-타르트레이트를 이용한 에스-(-)-암로디핀의 제조방법 |
EP1407773A1 (en) | 2002-10-08 | 2004-04-14 | Council of Scientific and Industrial Research | A process for the preparation of s (-) amlodipine salts |
US6608206B1 (en) | 2002-10-30 | 2003-08-19 | Council Of Scientific & Industrial Research | Process for making S(-) Amlodipine salts |
CN1882543A (zh) * | 2003-11-20 | 2006-12-20 | 科学与工业研究委员会 | 制备手性氨氯地平盐的方法 |
-
2005
- 2005-10-17 PT PT05792229T patent/PT1802576E/pt unknown
- 2005-10-17 AT AT05792229T patent/ATE399154T1/de active
- 2005-10-17 JP JP2007537409A patent/JP4932728B2/ja not_active Expired - Fee Related
- 2005-10-17 ES ES05792229T patent/ES2307209T3/es active Active
- 2005-10-17 WO PCT/IB2005/003108 patent/WO2006043148A1/en active IP Right Grant
- 2005-10-17 KR KR1020067024198A patent/KR101130622B1/ko active IP Right Grant
- 2005-10-17 EP EP05792229A patent/EP1802576B1/en not_active Not-in-force
- 2005-10-17 RU RU2006138705/04A patent/RU2376288C2/ru active
- 2005-10-17 BR BRPI0511095A patent/BRPI0511095B8/pt active IP Right Grant
- 2005-10-17 DE DE602005007763T patent/DE602005007763D1/de active Active
- 2005-10-17 US US11/574,781 patent/US7858801B2/en not_active Expired - Fee Related
-
2010
- 2010-09-30 US US12/895,303 patent/US8445688B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US20080262239A1 (en) | 2008-10-23 |
BRPI0511095A (pt) | 2007-12-26 |
US7858801B2 (en) | 2010-12-28 |
WO2006043148B1 (en) | 2006-06-08 |
KR101130622B1 (ko) | 2012-04-02 |
KR20070062946A (ko) | 2007-06-18 |
PT1802576E (pt) | 2008-09-15 |
ATE399154T1 (de) | 2008-07-15 |
EP1802576B1 (en) | 2008-06-25 |
RU2376288C2 (ru) | 2009-12-20 |
ES2307209T3 (es) | 2008-11-16 |
WO2006043148A1 (en) | 2006-04-27 |
BRPI0511095B1 (pt) | 2021-01-19 |
EP1802576A1 (en) | 2007-07-04 |
JP2008517050A (ja) | 2008-05-22 |
JP4932728B2 (ja) | 2012-05-16 |
DE602005007763D1 (de) | 2008-08-07 |
US8445688B2 (en) | 2013-05-21 |
US20110021783A1 (en) | 2011-01-27 |
RU2006138705A (ru) | 2008-05-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0511095B8 (pt) | um processo para produção de enantiômero de anlodipino em alta pureza ótica | |
EP2676952A3 (fr) | Procédé de préparation et formes cristallines IV des énantiomères optiques du modafinil | |
ATE546423T1 (de) | Verfahren zur herstellung von alkyl(meth)acrylaten | |
EA200900536A1 (ru) | Способ получения хиральных 8-(3-аминопиперидин-1-ил) ксантинов | |
DE60329527D1 (de) | Verfahren zur herstellung von photochromischen kontaktlinsen | |
BR0107425A (pt) | Processo para a preparação compostos de derivados de ácido 3-hidróxi picolìnico e uso dos compostos | |
ATE544754T1 (de) | Verfahren zur herstellung von ivabradinhydrochlorid | |
DE60327788D1 (de) | Verfahren zur herstellung von polytrimethylenterephthalt-fasern | |
DE602004027229D1 (de) | Verfahren zur herstellung von photonischer kristallfaser | |
ATE485273T1 (de) | Verfahren zur optischen auftrennung von amlodipin | |
DK1440947T3 (da) | Fremgangsmåde til fremstilling af en optisk fiber præform og en optisk fiber præform og en optisk fiber fremstillet ved fremgangsmåden | |
ATE445601T1 (de) | Verfahren zur herstellung von carvedilol und seinen enantiomeren | |
DE60320201D1 (de) | Verfahren zur Herstellung von optischen Polyimid-Wellenleitern. | |
DE50301594D1 (de) | Verfahren zur Herstellung von Emulsionspolymeren mit hoher Reinheit | |
DE50101601D1 (de) | Verfahren zur herstellung eines brillenglases | |
BRPI0513881A (pt) | processo para a preparação de compostos opticamente ativos | |
ATE466010T1 (de) | Verfahren zur herstellung von candesartan | |
DE602004021605D1 (de) | Verfahren zur herstellung von enantiomerenreinem mirtazapin | |
DE60126744D1 (de) | Verfahren zur herstellung von 2-hydroxy-4-methylthio-buttersäure-estern | |
DE60119192D1 (de) | Für optisch funktionierende Elemente geeignetes Glas und Verfahren zu dessen Herstellung | |
ATE428707T1 (de) | Verfahren zur herstellung des (s)-enantiomers von omeprazol | |
DE602004019523D1 (de) | Verfahren zur herstellung von optisch aktivem chroman-carbonsäureester | |
ATE555093T1 (de) | Verfahren zur herstellung einer (s)-1-alkyl-2i,6i-pipecoloxylididverbindung | |
DE602006002650D1 (de) | Verfahren zur Herstellung von Paroxetin Hydrochlorid Hemihydrat | |
DE602004030571D1 (de) | Verfahren zur herstellung optisch aktiven 1-alkyl-substituierter 2,2,2-trifluorethylamins |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06T | Formal requirements before examination [chapter 6.20 patent gazette] | ||
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS. |
|
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 19/01/2021, OBSERVADAS AS CONDICOES LEGAIS. |
|
B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 17/10/2005 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF |